Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
NDC API
0
VMF
0
Canada
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Amlodipine
2. Amlodipine Besylate
3. Amlodipine Maleate (1:1)
4. Amlodipine, (+-)-isomer
5. Amlodipine, (+-)-isomer, Maleate (1:1)
6. Amlodipine, (r)-isomer
7. Amlodipine, (s)-isomer, Maleate (1:1)
8. Amlodis
9. Amlor
10. Astudal
11. Istin
12. Norvasc
1. 88150-47-4
2. Amvaz
3. Amlodipine (maleate)
4. Amlodipine Maleate [usan]
5. Cq27g2bzjm
6. 1357024-06-6
7. Uk-48,340-11
8. Amlodipine (+-)-form Maleate
9. (z)-but-2-enedioic Acid;3-o-ethyl 5-o-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate
10. 3-ethyl 5-methyl 2-((2-aminoethoxy)methyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate Maleate
11. Uk-48340-11
12. Amlodipine Maleate (usan)
13. Unii-cq27g2bzjm
14. Uk 48,340-11
15. Amvaz (tn)
16. 3-ethyl 5-methyl (+-)-2-((2-aminoethoxy)methyl)-4-(o-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate, Maleate (1:1)
17. Schembl121252
18. Amlodipine Maleate [mi]
19. Chembl1200984
20. Hy-b0317a
21. Dtxsid601027708
22. Amlodipine Maleate [mart.]
23. Amlodipine Maleate [who-dd]
24. Bcp12616
25. Mfcd02259457
26. S5966
27. Akos015962119
28. Ac-4701
29. Cs-3987
30. Amlodipine Maleate [orange Book]
31. 3,5-pyridinedicarboxylic Acid, 2-((2-aminoethoxy)methyl)-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-, 3-ethyl 5-methyl Ester, (+-)-, (z)-2-butenedioate (1:1)
32. As-14630
33. Ba164165
34. D02914
35. 150a474
36. Q27275625
37. 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-3-ethoxycarbonyl-5-methoxycarbonyl-6-methyl-1,4-dihydropyridine Maleate
38. 3,5-pyridinedicarboxylic Acid, 2-((2-aminoethoxy)methyl)-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-, 3-ethyl 5-methyl Ester, (+/-)-, (z)-2-butenedioate (1:1)
39. 3,5-pyridinedicarboxylic Acid,2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-,3-ethyl 5-methyl Ester, (2z)-2-butenedioate (1:1)
40. 3-ethyl 5-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate Maleate (1:1)
41. 3-ethyl5-methyl2-((2-aminoethoxy)methyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylatemaleate
Molecular Weight | 524.9 g/mol |
---|---|
Molecular Formula | C24H29ClN2O9 |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 11 |
Rotatable Bond Count | 12 |
Exact Mass | 524.1561582 g/mol |
Monoisotopic Mass | 524.1561582 g/mol |
Topological Polar Surface Area | 175 Ų |
Heavy Atom Count | 36 |
Formal Charge | 0 |
Complexity | 766 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 1 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Antihypertensive Agents
Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)
Calcium Channel Blockers
A class of drugs that act by selective inhibition of calcium influx through cellular membranes. (See all compounds classified as Calcium Channel Blockers.)
Vasodilator Agents
Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
23
PharmaCompass offers a list of Amlodipine Maleate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Amlodipine Maleate manufacturer or Amlodipine Maleate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Amlodipine Maleate manufacturer or Amlodipine Maleate supplier.
PharmaCompass also assists you with knowing the Amlodipine Maleate API Price utilized in the formulation of products. Amlodipine Maleate API Price is not always fixed or binding as the Amlodipine Maleate Price is obtained through a variety of data sources. The Amlodipine Maleate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Norvasc manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Norvasc, including repackagers and relabelers. The FDA regulates Norvasc manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Norvasc API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Norvasc manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Norvasc supplier is an individual or a company that provides Norvasc active pharmaceutical ingredient (API) or Norvasc finished formulations upon request. The Norvasc suppliers may include Norvasc API manufacturers, exporters, distributors and traders.
click here to find a list of Norvasc suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Norvasc DMF (Drug Master File) is a document detailing the whole manufacturing process of Norvasc active pharmaceutical ingredient (API) in detail. Different forms of Norvasc DMFs exist exist since differing nations have different regulations, such as Norvasc USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Norvasc DMF submitted to regulatory agencies in the US is known as a USDMF. Norvasc USDMF includes data on Norvasc's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Norvasc USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Norvasc suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Norvasc Drug Master File in Korea (Norvasc KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Norvasc. The MFDS reviews the Norvasc KDMF as part of the drug registration process and uses the information provided in the Norvasc KDMF to evaluate the safety and efficacy of the drug.
After submitting a Norvasc KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Norvasc API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Norvasc suppliers with KDMF on PharmaCompass.
A Norvasc written confirmation (Norvasc WC) is an official document issued by a regulatory agency to a Norvasc manufacturer, verifying that the manufacturing facility of a Norvasc active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Norvasc APIs or Norvasc finished pharmaceutical products to another nation, regulatory agencies frequently require a Norvasc WC (written confirmation) as part of the regulatory process.
click here to find a list of Norvasc suppliers with Written Confirmation (WC) on PharmaCompass.
Norvasc Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Norvasc GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Norvasc GMP manufacturer or Norvasc GMP API supplier for your needs.
A Norvasc CoA (Certificate of Analysis) is a formal document that attests to Norvasc's compliance with Norvasc specifications and serves as a tool for batch-level quality control.
Norvasc CoA mostly includes findings from lab analyses of a specific batch. For each Norvasc CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Norvasc may be tested according to a variety of international standards, such as European Pharmacopoeia (Norvasc EP), Norvasc JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Norvasc USP).